https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2008-11-15 16:44:442016-11-25 16:45:042008 EORTC_In Vivo Activity of SGI-110, a Novel Hypomethylating Agent
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2008-08-25 14:10:082016-11-25 14:10:362008_A Dose Escalation, PK and PD Study of AT7519 in Patients with Refractory Solid Tumors
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2008-05-25 14:10:412016-11-25 14:11:072008 ASH_AT7519 is Active in CLL Patient Samples Independent of Stage
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2007-11-25 15:30:272016-11-25 15:30:482007 Gordon: Fragment Based Drug Design of AT13387 A Novel and Efficacious HSP90 Inhibitor
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2007-07-25 14:11:472016-11-25 14:12:322007 ASH_AT7519 is Active in Leukemia Models and Primary CLL Patient Samples
https://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svg00webadminhttps://astx.com/wp-content/uploads/2023/12/New_Home_Logo_RGB.svgwebadmin2007-04-25 14:12:422016-11-25 14:13:062007_Comparison of AT7519 in Solid Tumor and Hematological Cell Lines
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
